GSP 301 NS
Sponsors
Glenmark Specialty S.A.
Conditions
Perennial Allergic RhinitisSeasonal Allergic RhinitisSeasonal Allergic Rhinitis (SAR)
Phase 3
Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
CompletedNCT02631551
Start: 2016-03-31End: 2016-07-31Updated: 2018-09-25
Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)
CompletedNCT02709538
Start: 2016-04-30End: 2017-07-31Updated: 2020-02-26
Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
CompletedNCT02870205
Start: 2016-08-31End: 2017-01-31Updated: 2018-04-06
Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
CompletedNCT03463031
Start: 2018-03-16End: 2018-11-14Updated: 2019-10-08